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Background: To investigate the drug resistant gene profiles and molecular typing of Acinetobacter baumannii
isolates collected from clinical specimens in a comprehensive hospital, Jiangsu province.
Methods: This study included 120 patients in a comprehensive hospital with drug-resistant A. baumannii infections
on clinical specimens from October 2011 to December 2013. Antibiotic susceptibility test was determined by Vitek
2 Compact system. OXA-51, OXA-23, OXA-24, OXA-58, VIM, IMP, SHV, GES, TEM, AmpC, qacEΔ1-sul1, intI l, CarO, aac(6′)-Ib,
and aac(6′)-II were analyzed by PCR. The analysis of molecular typing for 50 multidrug resistant A. baumannii isolates
was performed by PFGE.
Results: A total of 64(53%) isolates were multidrug-resistant A.baumannii. The antibiotic susceptibility tests showed that
the resistant rates to common antibiotics of mutidrug-resistant A. baumannii were extremely high, most of which over
60%. One hundred and ten isolates harbored OXA-51 (91.7%), 100 for OXA-23(83.3%), 103 for VIM-1(85.8%), 90 for AmpC
(75.00%), 50 for aac(6′)-Ib(41.7%), 77 for the loss of CarO (64.2%), 85 for intl1(70.8%), and 64 for qacEΔ1-sul1(53.33%),
while OXA-24 was undetected. Fifty multidrug-resistant A. baumannii isolates belong to 14 clones according to the PFGE
DNA patterns. Main clone A includes 24 isolates, while clone B and clone C includes 6 and 9 isolates, respectively and
others with no common source identified.
Conclusion: There is high morbidity of A. baumannii infections in the hospital, especially in ICU and sputum is the
most common sample type.The mainly drug-resistant genes of A. baumannii are OXA-51, OXA-23, and VIM-1 in the
hospital. Clonal dissemination provides evidence for the prevalence of multidrug-resistant A. baumannii among clinical
isolates. It is suggested that there is an urgent need for effective control and prevention measures.
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Acinetobacter baumannii (A.baumannii) is a non-
fermentative, gram-negative, conditional pathogenic bac-
terium, which can colonize and survive for prolonged
period under a wide range of environmental conditions,
such as hospital environment and human skin [1].
Meanwhile, A. baumannii is an emerging opportunistic
nosocomial pathogen, with increasingly global prevalence,* Correspondence: wuqian@njmu.edu.cn
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unless otherwise stated.responsible for a variety of nosocomial infections
including nosocomial pneumonia, blood infection,
urinary tract infection, surgical wound infection, etc.,
especially for patients in intensive care unit (ICU)
[2,3]. Its great capacity to survive in low-moisture
environments and its ability to develop resistance to
antimicrobial agents afford A. baumannii the possibil-
ity of spreading in hospitals. The increasing threat of
antibiotic resistance in microbes impacting on the
patient outcomes has been recognized as a challenge
for treatment of clinical infection with broad spectrum
antibiotics use. According to the report from CHINET,
2012, surveillance data reveal that the resistance rates
of Acinetobacter spp. (A. baumannii accounted forhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and 59.4%, respectively [4]. What’s more, multidrug
resistant A. baumannii, defined as resistant to at least
three different groups of antibiotics, causes numerous
nosocomial outbreaks and health care–associated in-
fections around the world [1]. The identification of
drug resistance mechanisms in A. baumannii will im-
prove the outcome of infections caused by this organ-
ism. The resistance mechanisms of A. baumannii are
complex, which include activating or production of en-
zyme, the integron formation, outer membrane perme-
ability, biofilm formation, drug exocytosis mechanism
and so on [5-9].
Carbapenem resistance in A.baumannii is increasingly
being observed worldwide [5]. The most important
mechanism of carbapenem resistance in A. baumannii
is the enzymatic hydrolysis mediated by carbapenem-
hydrolyzing β-lactamases, including class A (TEM, SHV,
and GES), class B (IMP, VIM, and SIM), class C (AmpC),
and class D (OXA-23-like, OXA-24-like, OXA-51-like,
and OXA-58-like) [10]. Resistance to aminoglycosides
in A. baumannii is mainly mediated by the production
of aminoglycosides-modifying enzymes (AMEs). The
most frequent AMEs in A. baumannii are AAC(6′)-Ib
and AAC(6′)-II [3,11]. What’ more, the loss of outer-
membrane protein(OMP) and the acquisition of class 1
integron are also contributed to an increasing incidence of
drug resistance [12]. In addition, many commercial prod-
ucts based on ammonium quaternary compounds (QAC)
are currently used in considerable quantities as antiseptic
agents in hospitals, but due to the intrinsic and chronic
resistance to QAC, infections with A. baumannii are
growing [13].
To date, there are few reports of combinations of dif-
ferent resistance mechanisms, but there is a correlation
of antimicrobial resistance with the enzyme production
and porin and integrons. In the present study, from
2011 to 2013, surveillance at a provincial hospital in
Jiangsu detected 120 drug-resistant A. baumannii
isolates. We aimed to analyze the genetic linkage and
drug-resistance gene profiles of these drug-resistant
A. baumannii isolates and investigate various mecha-
nisms of drug resistance in isolates.
Materials and methods
Subjects and bacterial isolates
This investigation was conducted at a comprehensive
hospital in Nanjing, Jiangsu, China, from Oct 2011 to
Dec 2013. Written informed consent was obtained from
the participants for the use of samples in this study. This
study was approved by the Nanjing Medical University
Clinical Research Ethics Committee, Nanjing, China. No
patients received antibiotic therapy before samples were
collected. All the clinical isolates were routinely collectedand stored at −80°C until use. One hundred and twenty
A. baumannii strains were isolated from clinical sam-
ples. Multidrug resistant A. baumannii was defined as
A. baumannii isolates which were resistant to more
than 3 classes of antimicrobials.
Antibiotic susceptibility testing
A. baumannii identification and general antimicrobial
susceptibilities were performed using Vitek 2 Compact
system (bioMérieux, Inc., Marcy-l’Etoile, France). Escheri-
chia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC
27853), and Staphylococcus aureus (ATCC 29213) were
used as quality control strains. Susceptibility results were
interpreted according to the Clinical and Laboratory
Standards Institute (CLSI) guidelines.
PCR of drug resistant genes
Genomic DNA of A.baumannii isolates was extracted
using TIANamp Bacteria DNA Kit(Tiangen). PCR was
performed using Taq PCR Master Mix(TaKaRa).Primers
were synthesized by Jierui, Shanghai. The details of pri-
mer sequences were showed in Table 1. Each reaction
was performed in a final volume of 50 μl consisting of
25 μl Taq Mix, 1 μl primers, 1 μl DNA template and
22 μl RNase Free H2O. OXA-51 and 16S rRNA was used
as the internal control. The cycling conditions were as
follows: an initial denaturation step at 94°C for 5 min,
followed by 30 cycles at 94°C for 30 s, 55°C for 30 s and
72°C for 90 s. Then the PCR products were electropho-
resed in agarose gel to detect the target band.
Molecular typing by pulsed-field gel electrophoresis
Pulsed-field gel electrophoresis (PFGE) was performed
using previously described methods [14]. In brief, the
purified bacterial genomic DNA was digested by the
restriction enzyme ApaI( TaKaRa), and the fragments
were separated in a CHEF Mapper system (Bio-Rad La-
boratories, Hercules, CA, USA) with pulses ranging
from 5 to 20 seconds at a voltage of 5 V/cm and switch
angle of 120° for 19 hours at 14°C. And then gels were
stained with ethidium bromide and DNA patterns were
acquired by Bio-Rad Vilber Lourmat. The PFGE profiles
were interpreted according to Tenover et al. [15]. We
used BioNumerics software (Applied Maths, Kortrijk,
Belgium) to analyze similarities between digitized
PFGE outputs. The Between-groups linkage method
was used to analyze hierarchic clustering. The classi-
fication criteria is as followed:(1) The completely con-
sistent patterns are defined as the same clone, for
example, Clone A. (2) If there are 1 to 3 different band
compared with Clone A, define it as subtype (Clone
A1…Clone An). (3)If there are over 3 different stripes,
define it as another clone, for example, Clone B, Clone C,
and Clone D etc.
Table 1 The sequence of primers used in this study
Target gene Primer Sequence product size(bp)
blaOXA-51-like OXA-51-like F TAATGCTTTGATCGGCCTTG 353
OXA-51-like R TGGATTGCACTTCATCTTGG
blaOXA-23-like OXA-23-like F GATCGGATTGGAGAACCAGA 501
OXA-23-like R ATTTCTGACCGCATTTCCAT
blaOXA-24-like OXA-24-like F TTCCCCTAACATGAATTTGT 1024
OXA-24-like R GTACTAATCAAAGTTGTGAA
blaOXA-58-like OXA-58-like F TGGCACGCATTTAGACCG 507
OXA-58-like R AAACCCACATACCAACCC
blaIMP-1 IMP F CTACCGCAGCAGAGTCTTTAC 587
IMP R AACCAGTTTTGCCTTACCAT
blaVIM-1 VIM F ATTCCGGTCGGMGAGGTCCG 633
VIM R GAGCAAGTCTAGACCGCCCG
blaSHV SHV F GGTTATGCGTTATATTCGCC 865
SHV R TTAGCGTTGCCAGTGCTC
blaGES GES F ATGCGCTTCATTCACGCAC 392
GES R ATTTGCTGATTTCGCTCGG
blaTEM TEM F ATCAGCAATAAACCAGC 516
TEM R CCCCGAAGAACGTTTTC
16S rRNA 16S-8F AGAGTTTGATCCTGGCTCAG 1499
16S-1493R ACGGCTACCTTGTTACGACTT
blaAmpC AmpC F CGACAGCAGGTGGAT 513
AmpC R GGTTAAGGTTGGGATG
aac(6′)-Ib aac(6′)-Ib F ATGACTGAGCATGACCTTGC 519
aac(6′)-Ib R TTAGGCATCACTGCGTGTTC
aac(6′)-II aac(6′)-II F GAGCGACCGACTCTTGATG 326
aac(6′)-II R CGTATGGCTCGATGGTTGTT
CarO CarO F CAGAGCCTTTTCCTAAGGAGAA 916
CarO R GCTCACCTGATGCTGACATTAA
qacΔE 1-sul1 qacEΔ1-sul1 F TAGCGAGGGCTTTACCTAAGC 300
qacEΔ1-sul1 R ATTCAGAATGCCGAACACCG
intl 1 intl 1 F ACGAGCGCAAGGTTTGGT 565
intl 1 R GAAAGGTCTGGTCATACATG
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Statistical analyses were performed using SPSS18.0.
P values <0.05 are considered statistically significant.
Statistical significance was assessed via χ2 test of Fisher’s
exact test for categorial variables and Student’s test or
the Mann–Whitney U test for continuous variables.
Results
The characteristics of drug-resistant A. baumannii infection
subjects
During the study period there were 120 strains isolated
from adults aged 23 to 98 years old. The average age of
the patients was 73.43 ± 13.09 years, and male–femaleratio was 1.24:1. The age distribution were shown as
followed in Table 2. A. baumannii isolates were mainly
distributed in respiratory department, ICU, and emer-
gency department, accounting for 21.7%, 16.7% and 11.7%,
respectively. while multidrug-resistant strains, were mainly
in ICU and emergency department, accounting for 29.7%
and 20.3%, respextively. According to Chi-square test,
there were statistical differences in the incidence of
multidrug-resistant strains among different wards (χ2 =
195.504, P < 0.001) (Table 3). The strains were mainly
isolated from sputum(112, 93.3%), and the others were
from blood, urine, endotracheal tube suction, broncho-
alveolar and so on.
Table 2 Age distribution between patients with
multidrug-resistant and non-multidrug-resistant
A. baumannii
Age No. of patients with
multidrug-resistant




<40 2 0 2
40~ 2 2 4
50~ 1 6 7
60~ 13 9 22
70~ 25 21 46
>80 21 18 39
Total 64 56 120
Table 4 Antibiotics resistance of multidrug-resistant
A. baumannii isolates
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The susceptibility patterns of the 120 A. baumannii
strain were shown in Table 4. Among 120 drug resistant
strains, 64 were multidrug resistant. Most exhibited re-
sistance across different classes of agents notably imipe-
nem, gentamicin, ampicillin/sulbactam, ceftazidime, and
ciprofloxacin.
The detection of drug-resistant genes in these
A. baumannii isolates
All 120 isolates were identified as A. baumannii using
16S rRNA gene validation. With regard to the 120 iso-
lates, one hundred and ten strains carried OXA-51 gene
characteristic of A. baumannii. The OXA-23 genes were
carried by 100 strains. Coexistence of the OXA-51 and
the OXA-23 genes was detected in 95 strains. Only one
strain harbored OXA-58 gene, and all strains were nega-
tive for OXA-24 gene. In multidrug resistant strains,
73.4% of which were positive for SHV gene, as Amber
class A of β-lactamases; 95.3% for VIM, one of MBL
genes; 82.8% for AmpC β-lactamases; 50.0% for aac(6′)-
Ib, the most frequent aminoglycoside-modifying enzymes;Table 3 Ward distribution between patients with
multidrug-resistant and non-multidrug-resistant
A. baumannii
Ward No. of patients with
multidrug-resistant




Respiration 6 20 26
ICU 19 1 20
Emergency 13 1 14
Geriatrics 5 8 13




Cardiology 4 4 8
Others* 3 14 17
*Others: Department of wounds, rheumatology, Chinese Acupuncture, E.N.T.,
oncology, gastroenterology, hematology and cardiothoracic surgery.32.8% for CarO, outer membrane protein; 82.8% for class
1 integrase( Intl 1); 56.3% for qac△E1-sul1, which is related
to resistance to quaternary ammonium compounds and
sulfonamide (Table 5).
PFGE typing of multidrug-resistant A. baumannii isolates
Figure 1 showed that the PFGE results of the multidrug
resistant A. baumannii isolates. More than 25 DNA
fragments were observed in each isolate. The results of
genetic linkage were presented as a dendrogram. PFGE
revealed that the isolates had diversity with multivariate
clones. Fifty strains were typed into 14 clones. Clone A
had 25 isolates (50%), including A1 for 19 , and A2 for 6.
Clone B had 5. Clone C had 9,including C1 for 5, C2 for 2,
and C3 and C4 for 1,respectively. The others had no
common resource. Clonal distribution was shown as
followed in Table 6.
Discussion
Acinetobacter baumannii, recently as an increasingly
common pathogen, is closely associated with hospital
acquired infection [16]. A. baumannii has the character-
istics of strong viability and rapid development of drug
resistance ability and has raised an important challenge
to our therapeutic approach [17]. In this paper, we char-
acterized the occurrence of drug resistant of A. bauman-
nii isolates in a hospital in Nanjing. From 2011 to 2013,
Table 5 The detective rate of drug-resistant genes between groups
Gene Total
rate (%)
Multidrug-resistant group (n = 64) Non-multidrug-resistant group (n = 55)
No. rate (%) No. rate (%)
blaOXA-51-like 91.7 64 100.0 46 82.1
blaOXA-23-like 83.3 58 90.6 42 75.0
blaOXA-24-like 0 0 0 0 0
blaOXA-58-like 0.8 1 1.5 0 0
blaIMP-1 5.0 2 3.1 4 7.1
blaVIM-1 85.8 61 95.3 42 75
blaTEM 25.8 16 25.0 15 26.8
blaSHV 66.7 47 73.4 33 58.9
blaGES 3.3 1 1.6 3 5.4
16S rRNA 100.0 65 100.0 55 100.0
blaAmpC 75.0 53 82.8 37 66.1
aac(6′)-Ib 41.7 32 50.0 18 32.1
aac(6′)-II 2.5 1 1.6 2 3.6
Loss of CarO 64.2 43 67.2 34 60.7
Intl 1 70.8 53 82.8 32 57.1
qacΔE1-sul1 53.3 36 56.3 28 50.0
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source of 120 strains was mainly from older patients.
There were 107 patients aged more than 60 years old
(89.2%). The main ward for drug resistant A. baumannii
isolate is ICU and respiratory department. The main
source of A. baumannii isolates was respiratory specimen.
These were consistent with data presented by others [18].
In other words, respiratory tract infection is the common
manifestation of drug resistant A. baumannii infection.
Overall, the resistance rates were high for most anti-
microbial agents. The resistance rate to imipenem, ampi-
cillin/sulbactam, ceftazidime, cefepime, aztreonam, and
ciprofloxacin were more than 90% in multidrug-resistant
A. baumannii. Carbapenems have been the choice in
treating infections caused by A. baumannii [8]. However,
the number of carbapenem-resistant A. baumannii strains
has increased recently [19]. The acquisition of carbapenem
resisrance in A. baumannii can be mainly due to the
production of class D carbapenem hydrolyzing enzymes
OXA-β-lactamases(OBLs)and class B metallo β-lactamases
(MBLs) [20]. As shown in our study, sixty-four and
58 of the 64 multidrug-resistant strains studied here
carried respectively OXA-51 and OXA-23 genes. More-
over, 58 isolates were positive for both OXA-51 and
OXA-23 genes. our data support those of other studies
demonstrated that OXA-51 may be used as a marker to
identify A. baumannii [21]. The OXA-23 genes have
been documented in strains associated with outbreaks
of carbapenem resistant A. baumannii in Asia, Europe
and South America [22]. Only one strain is OXA-58positive and all strains were negative for OXA-24. OXA-
58 belongs to OXA-58 cluster, and OXA-24 belongs
to OXA-40 cluster, which has been both reported in
Europe and the United States.
And 103 of 120(85.8%) isolated are VIM-1 positive.
Our finding indicates that VIM -producing A. bauman-
nii is more prevalent and that MBL-producing A. bau-
mannii is increasing [5]. The percentage of wards with
MBL-producing isolates might have been higher if a
larger number of carbapenem-non susceptible isolates
had been collected for this study.
Screening for genes encoding for AMEs demonstrated
that 50 isolates contained the acetyltransferase gene aac
(6′)-Ib. Few articles were published describing the pres-
ence of the aminoglycoside-encoding genes in strains
isolated in china. In Guangzhou, Yang et al. have re-
ported that 89.0% of 73 amikacin-resistant A. bauman-
nii. were aac(6′)-Ib positive. And it is interesting that
the aac(6′)-Ib gene is often present in integrons, trans-
posons, and plasmids [23].
In addition to this enzymatic resistance, the loss of
membrane permeability, due to alterations in specific
porin, is an intrinsic carbapenem resistance mechanism
in A. baumannii. A 29 kDa OMP, designated as CarO, if
disrupted by insertion sequence, changes in the primary
structure or decreased expression, would have a dra-
matic impact on the entry of antibiotic in the cell, thud
contributing to resistance to this antibiotic [24]. But this
is not limited to carbenem-resistant strains of A. bau-
mannii. We showed the loss expression of carO in 77
Figure 1 Molecular typing of representative multidrug resistant A. baumannii isolates by PFGE. Participating wards, clone type, and source
of the samples were also indicated. GE: Geriatrics; R: Respiration; C: Cardiology; E: Emergency; NEU: Neurology; W:wound; GA: Gastroenterol; NEP:
Nephrology; HE: Hematology; UL: Urology; S:sputum; CF: cerebrospinal fluid; U:urine.
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ability is necessary.
Quaternary ammonium compounds(QAC) are used as
antiseptics for the skin in hospitals. Until now many
Gram-negative bacteria resistant to QAC have beenreported. Resistance mechanisms are coded by qacE and
qacΔE1, whose products are transmembrane proteins
[25]. The qacE and qac EΔ1 genes are commonly found
in Gram-negative bacteria, which are located in con-
served sequences of integron class 1. The qacEΔ1 gene
Table 6 The distribution of clone strains in each ward
Ward Clone
A1 A2 B C1 C2 C3 C4 D E F G H I J K L M N
ICU 6 0 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0
Respiration 3 2 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0
Neurology 2 1 1 1 2 0 0 0 0 0 1 0 0 0 0 0 0 0
Emergency 4 0 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Geriatrics 1 2 0 2 0 0 0 1 0 1 0 0 0 0 0 0 0 0
Others* 3 1 1 1 0 0 0 0 1 0 0 1 1 0 1 0 1 1
*Others refer to Department of Cardiology, Urology, Nephrology, Hematology, and Gastroenterology.
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drug transfer gene [26]. Sulfonamides act as a structural
analogue of ρ-amino-benzoic acid and bind dihydrop-
teroate synthase (DHPS), a catalytic enzyme in the folic
acid biosynthesis pathway, resulting in the inhibition of
dihydrofolic acid formation [27]. Resistance is conferred
from the acquisition of an alternative DHPS gene (sul).
One of the three known alternative DHPS genes, sul1, is
usually located on the conserved region of integron class
1 [28]. The class 1 integrons are one of the most fre-
quent elements in the acquisition, abundance, main-
tenance and spread of antimicrobial resistance gene
cassettes among gram-negative bacteria isolated from
clinical samples [29]. An integron possesses a gene for
an integrase (intI), that permits the expression of gene
cassettes incorporated in the variable region [30]. And
3′-conserved region at the end of the variable region
contains the qacEΔ1 gene, followed by the sul1 gene.
The class 1 integrons confer a benefit to the bacteria
due to their ability to acquire gene cassettes that could
provide advantages for survival in hostile environments
[31]. We evaluated genetic elements, sul1 and qacEΔ1
genes and genetic elements associated to lateral genetic
transfer, intI1, genes, which comprise the genetic plat-
forms of class 1 integrons. Genomic detection of intI1
and qacΔE1-sul1 showed that 85 (70.8%) and 64 (53.3%)
were positive, out of 120 A. baumannii isolates, respect-
ively. Resistance genes related to QAC and sulfonamides
antibiotics are both carried by class 1 integrons, so it
increases concerns about gene expression that is resist-
ant to QAC and sulfonamides, along with the increasing
resistance to antibiotics by class 1 integrons. However, it
is difficult to identify the sources of class 1 integrons
from “environmental” or “clinical” one.
Pulsed-field gel electrophoresis (PFGE )which is based
on the length polymorphism of bacterial chromosome
DNA restriction fragments, is still considered the gold
standard for typing outbreak-related isolates of A. bau-
mannii [32]. It can be used to separate large digested
DNA fragments, and then determine bacterial genotyp-
ing through the comparison of DNA band patterns. Inmany health care institutions, multidrug-resistant A.
baumannii infection demonstrates complex epidemio-
logic profiles and coexistence of multiple strain type.
PFGE results showed that among the multidrug-
resistant A. baumanii strains in the hospital, DNA fin-
gerprinting by pulsed-field gel electrophoresis showed
fourteen clusters. Twenty-five of the 50 multidrug-
resistant A. baumannii strains belonged to clone A, and
type A1 was the most predominant (19 of 50 strains) in
every ward. Based on the data presented, the interhospi-
tal transmission of multidrug-resistant A. baumanii iso-
lates was apparent. These data also suggested that cross
transmission between patients may contributed to the
rise in the rates of multidrug resistance. Type A2, B, C1,
C2, C3, C4 and other minor epidemic strains spread in
different wards, which indicated that resistance towards
antibiotic become more common in the hospital. In
addition, type A1, B, C3 and C4 strains was found in
ICU, type A1, A2, J and L in respiratory wards, type A1,
A2, B, C1, C2, and G in neurology wards, and type A2,
C1, D, and F in geriatrics ward, respectively, which sug-
gested that the mix of multiple types of drug resistant
strains make clinical treatment more difficult. Therefore,
active surveillance is needed to detect and prevent the
dissemination of such isolates.
The main limitation of this study is that it was con-
fined to a single centre and it would be valuable to
extend the origin of the strains. Another limitation is the
small sample size which led to a lack of power to deter-
mine the individual effects of each broad spectrum
antibiotics.
In conclusion, the emergence of broad-spectrum anti-
biotic resistance profiles in A. baumannii clinical isolates
is worrying in the hospital. The mechanism of multidrug
resistance in A. baumannii has not yet been fully under-
stood. Multiple mechanisms are likely to work in syner-
gism to produce this phenotype. our results highlight
that enhanced surveillance and health policies for the
detection and control of these MDR pathogens are
urgently needed to avoid the emergence and spreading
of such organism.
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